RedHill Biopharma (RDHL) Accounts Payables (2011 - 2026)
RedHill Biopharma (RDHL) recorded Accounts Payables of $584,000 in the quarter ended Jun 30, 2026, down 30.1% from $835,000 a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Accounts Payables (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, RedHill Biopharma reported Accounts Payables of $731,000, down 37.4% from the prior year.
- Annual Accounts Payables has declined for four straight years, with a five-year compound annual growth rate of -42.4% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Accounts Payables came in at $1.17 million in the year ended Dec 31, 2024 (-64.4%), $3.28 million in the year ended Dec 31, 2023 (-22.5%), $4.23 million in the year ended Dec 31, 2022 (-63.7%) and $11.66 million in the year ended Dec 31, 2021 (+1.0%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Accounts Payables since the quarter ended Dec 31, 2016.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 132.1% in the quarter ended Sep 30, 2021, against a decline of 68.6% in the quarter ended Sep 30, 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.90 Bn | 1,139.49 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 643.26 Bn | 561.78 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 501.85 Bn | 474.96 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.72 Bn | 325.10 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 302.56 Bn | 266.55 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 268.35 Bn | 242.04 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 193.22 Bn | 167.42 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.25 Bn | 118.90 Bn | 10.94 Bn | 4.58 Bn |
| 10 | RedHill Biopharma | 1.37 Mn | -15.25 Mn | - | 584,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 584,000.00 |
| Dec 31, 2025 | 731,000.00 |
| Jun 30, 2025 | 835,000.00 |
| Dec 31, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 4.37 Mn |
| Dec 31, 2022 | 4.23 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | 4.37 Mn |
| Mar 31, 2022 | 5.71 Mn |
| Dec 31, 2021 | 11.66 Mn |
| Sep 30, 2021 | 15.25 Mn |
| Jun 30, 2021 | 13.31 Mn |
| Mar 31, 2021 | 6.54 Mn |
| Dec 31, 2020 | 11.55 Mn |
| Sep 30, 2020 | 6.57 Mn |
| Jun 30, 2020 | 5.31 Mn |
| Mar 31, 2020 | 3.19 Mn |
API Access
RedHill Biopharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();